World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
88
Citations
40437
World Ranking
774
National Ranking
410

John M. Sedivy publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where John M. Sedivy sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 214 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

John M. Sedivy D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where John M. Sedivy sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 88 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

John M. Sedivy is affiliated with Brown University in the United States. Their research primarily focuses on biochemistry, genetics, and molecular biology, with significant contributions to medicine.

Their main subfields of study include molecular biology, physiology, plant science, immunology, and cardiology and cardiovascular medicine. Sedivy's work frequently addresses topics such as telomeres, telomerase, and senescence; chromosomal and genetic variations; CRISPR and genetic engineering; genetics, aging, and longevity in model organisms; cardiac fibrosis and remodeling; epigenetics and DNA methylation; and advanced biosensing and bioanalysis techniques.

The scientist has published extensively, with notable papers including:

  • Loss of epigenetic information as a cause of mammalian aging, 2023, Cell
  • The role of retrotransposable elements in ageing and age-associated diseases, 2021, Nature
  • Inflammation, epigenetics, and metabolism converge to cell senescence and ageing: the regulation and intervention, 2021, Signal Transduction and Targeted Therapy
  • CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD+ and NMN levels, 2020, Nature Metabolism
  • Guidelines for minimal information on cellular senescence experimentation in vivo, 2024, Cell

Frequently publishing in venues such as bioRxiv (Cold Spring Harbor Laboratory), The FASEB Journal, Cell, Cancer Research, and Signal Transduction and Targeted Therapy, Sedivy maintains a consistent presence in high-impact journals.

Collaborations feature prominently in their work. Notable frequent coauthors include Jill A. Kreiling, Vadim N. Gladyshev, Jef D. Boeke, Nicola Neretti, and Brett Baggett.

Best Publications

  • Requirement for p53 and p21 to Sustain G2 Arrest After DNA Damage

    Fred Bunz;A. Dutriaux;C. Lengauer;T. Waldman

  • Mitochondrial DNA Mutations, Oxidative Stress, and Apoptosis in Mammalian Aging

    G. C. Kujoth;A. Hiona;T. D. Pugh;S. Someya

  • Cellular Senescence: Defining a Path Forward

    Vassilis Gorgoulis;Peter D. Adams;Andrea Alimonti;Dorothy C. Bennett

  • Telomere Shortening Triggers Senescence of Human Cells through a Pathway Involving ATM, p53, and p21CIP1, but Not p16INK4a

    Utz Herbig;Wendy A Jobling;Benjamin P.C Chen;David J Chen

  • Cellular senescence in aging primates.

    Utz Herbig;Mark Ferreira;Mark Ferreira;Laura Condel;Laura Condel;Dee Carey;Dee Carey

  • Bypass of Senescence After Disruption of p21CIP1/WAF1 Gene in Normal Diploid Human Fibroblasts

    Jeremy P. Brown;Wenyi Wei;John M. Sedivy

  • Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP

    Kam Yeung;Thomas Seitz;Shengfeng Li;Petra Janosch

  • L1 drives IFN in senescent cells and promotes age-associated inflammation

    Marco De Cecco;Takahiro Ito;Anna P. Petrashen;Amy E. Elias

  • Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization

    Christopher M. Counter;William C. Hahn;Wenyi Wei;Stephanie Dickinson Caddle

  • Accumulation of senescent cells in mitotic tissue of aging primates.

    Jessie C. Jeyapalan;Mark Ferreira;John M. Sedivy;Utz Herbig

  • Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis

    Tammy Bowman;Martin A. Broome;Dominic Sinibaldi;Walker Wharton

  • Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination

    Maria K. Mateyak;Alvaro J. Obaya;Susumu Adachi;John M. Sedivy

  • Interventions to Slow Aging in Humans: Are We Ready?

    Valter D. Longo;Adam Antebi;Andrzej Bartke;Nir Barzilai

  • Identification of CDK4 as a target of c-MYC.

    Heiko Hermeking;Carlo Rago;Marino Schuhmacher;Qing Li

  • Regulation of cyclin-Cdk activity in mammalian cells.

    A.J. Obaya;J.M. Sedivy

  • Mechanism of Suppression of the Raf/MEK/Extracellular Signal-Regulated Kinase Pathway by the Raf Kinase Inhibitor Protein

    Kam Yeung;Petra Janosch;Brian McFerran;David W. Rose

  • Raf Kinase Inhibitor Protein Interacts with NF-κB-Inducing Kinase and TAK1 and Inhibits NF-κB Activation

    Kam C. Yeung;David W. Rose;Amardeep S. Dhillon;Diane Yaros

  • Cellular senescence and organismal aging.

    Jessie C. Jeyapalan;John M. Sedivy

  • c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points.

    Maria K. Mateyak;Alvaro J. Obaya;John M. Sedivy

  • Genomes of replicatively senescent cells undergo global epigenetic changes leading to gene silencing and activation of transposable elements

    Marco De Cecco;Steven W. Criscione;Edward J. Peckham;Sara Hillenmeyer

Frequent Co-Authors

Wenyi Wei
Wenyi Wei Beth Israel Deaconess Medical Center
Adam Antebi
Adam Antebi Max Planck Society
Claudio Franceschi
Claudio Franceschi University of Bologna
Walter Kolch
Walter Kolch University College Dublin
Peter D. Adams
Peter D. Adams Sanford Burnham Prebys Medical Discovery Institute
Stephen L. Helfand
Stephen L. Helfand Brown University
Linda Z. Penn
Linda Z. Penn University of Toronto
Harald Mischak
Harald Mischak University of Glasgow
David A. Sinclair
David A. Sinclair Harvard University
Ana Maria Cuervo
Ana Maria Cuervo Albert Einstein College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Molecular Biology in the USA opens doors to a broad range of healthcare and science careers. Many professionals leverage this background to pursue advanced degrees and certifications online. One popular route is nursing, which offers diverse opportunities and flexible program options. Prospective students often want to know how long to become a nurse practitioner, as timelines vary between traditional and accelerated pathways.

If you’re currently a registered nurse, you may be interested in learning about an rn to bsn in 6 months program, which provides a fast track to further credentials. Alternatively, some students explore rn to np bridge programs, allowing for seamless transitions from associate degrees to master’s degree specializations.

Salaries in specialized nursing can be lucrative. For example, understanding psychiatric mental health nurse practitioner salary trends by state can help professionals make informed decisions about their future. Exploring related online degrees and career pathways provides flexibility and adaptability in today’s rapidly changing healthcare landscape.

Best Scientists Citing John M. Sedivy

Trending Scientists

Recently Published Articles